Article Published 17 Oct 2025 Conception & Inventorship Under Pharmaceutical Patent Law: Lessons And Best Practices United States Intellectual Property UT Upadhye Tang
Article Published 17 Oct 2025 Environmental Developments To Watch In New England United States Environment BD Beveridge & Diamond
Article Published 17 Oct 2025 Recent Federal Developments For October 2025 United States Environment BC Bergeson & Campbell
Article Published 17 Oct 2025 The PBM Effect: Regulatory And Market Implications For Life Sciences Companies And Healthcare Providers United States Food, Drugs, Healthcare, Life Sciences BI Buchanan Ingersoll & Rooney PC
Article Published 16 Oct 2025 Update On Texas Executive Order GA-56 United States Cannabis & Hemp BI Buchanan Ingersoll & Rooney PC
Article Published 16 Oct 2025 Update: Status Of FTC Case Against Three Largest PBMs United States Food, Drugs, Healthcare, Life Sciences BI Buchanan Ingersoll & Rooney PC
Article Published 16 Oct 2025 FDA Approves Celltrion's Aflibercept Biosimilar United States Food, Drugs, Healthcare, Life Sciences GP Goodwin Procter LLP
Article Published 16 Oct 2025 Colorado Limits Medicaid Coverage Of Definitive Drug Testing United States Food, Drugs, Healthcare, Life Sciences PL Polsinelli LLP
Article Published 16 Oct 2025 Ohio's PBM Regulation Passed By House Of Representatives United States Food, Drugs, Healthcare, Life Sciences BI Buchanan Ingersoll & Rooney PC
Article Published 16 Oct 2025 Benesch Healthcare+ Dialysis & Nephrology Digest No. 69 United States Food, Drugs, Healthcare, Life Sciences B Benesch Friedlander Coplan & Aronoff LLP
Video Published 16 Oct 2025 Navigating Food And Dietary Supplements Labeling Litigation & Regulatory Hurdles In 2025 And Beyond (Video) United States Food, Drugs, Healthcare, Life Sciences SM Sheppard Mullin Richter & Hampton
Article Published 16 Oct 2025 Product Liability Considerations For Cannabis And Cardiovascular Risks United States Cannabis & Hemp WE Wilson Elser Moskowitz Edelman & Dicker LLP
Article Published 16 Oct 2025 White House Announces MFN Deal With Pfizer, Previews Additional Regulatory Action On Drug Prices United States Food, Drugs, Healthcare, Life Sciences MP Manatt, Phelps & Phillips LLP
Article Published 15 Oct 2025 FDCA: Fifth Circuit End-Run Suggests State Law Private Right Of Action United States Food, Drugs, Healthcare, Life Sciences FL Foley & Lardner
Article Published 15 Oct 2025 Holie Foods / Lotus – A Sweet Victory For Transparency On Sugar United States Media, Telecoms, IT, Entertainment GA Global Advertising Lawyers Alliance (GALA)
Article Published 14 Oct 2025 Advances In Plant Biotechnology Improving Health And Well-Being United States Intellectual Property JA J A Kemp LLP
Article Published 14 Oct 2025 Vaccine Coverage Complexities Set In As FDA Tightens Access To COVID Vaccines United States Food, Drugs, Healthcare, Life Sciences HB Hall Benefits Law
Article Published 14 Oct 2025 Rural Health Transformation Fund: Opportunities To Promote Health Through Nutrition United States Food, Drugs, Healthcare, Life Sciences MP Manatt, Phelps & Phillips LLP
Article Published 13 Oct 2025 FDA Continues Focus On AI Fronts, Seeks Public Comment On Measuring And Evaluating AI-enabled Medical Device Performance In The Real-World United States Food, Drugs, Healthcare, Life Sciences AG Akin Gump Strauss Hauer & Feld LLP
Article Published 13 Oct 2025 In Antitrust Settlement, California Imposes Unprecedented Controls On Private Equity Purchase Of Walgreens United States Antitrust/Competition Law BB Baker Botts LLP